Skip to content

Opening book details…

About this Medicine article

Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial by Johansen, Nicklas J; Dejgaard, Thomas F; Lund, Asger; SchlÃ1⁄4ntz, Camilla; Frandsen, Christian S; Forman, Julie L; Wewer Albrechtsen, Nicolai J; Holst, Jens J; Pedersen-Bjergaard, Ulrik; Madsbad, Sten; is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Johansen, Nicklas J; Dejgaard, Thomas F; Lund, Asger; SchlÃ1⁄4ntz, Camilla; Frandsen, Christian S; Forman, Julie L; Wewer Albrechtsen, Nicolai J; Holst, Jens J; Pedersen-Bjergaard, Ulrik; Madsbad, Sten;
Publisher
Elsevier ; The Lancet Publishing Group; Elsevier BV (ISSN 2213-8587)
Published
2020
Field
Medicine (Health Sciences)

More by Johansen, Nicklas J; Dejgaard, Thomas F; Lund, Asger; SchlÃ1⁄4ntz, Camilla; Frandsen, Christian S; Forman, Julie L; Wewer Albrechtsen, Nicolai J; Holst, Jens J; Pedersen-Bjergaard, Ulrik; Madsbad, Sten;

Browse all works by Johansen, Nicklas J; Dejgaard, Thomas F; Lund, Asger; SchlÃ1⁄4ntz, Camilla; Frandsen, Christian S; Forman, Julie L; Wewer Albrechtsen, Nicolai J; Holst, Jens J; Pedersen-Bjergaard, Ulrik; Madsbad, Sten;